|Bird Flu Vaccine for Humans|
Chinese State Food and Drug Administration granted on April 2, 2008 Beijing Kexing Bioproducts the permit to produce influenza vaccines for pandemics. The event makes China another country possessing the both technology and capacity to produce bird flu vaccines for humans, after the United States.
According to a briefing, the vaccine is designed to fence off H5N1 pandemics, enjoying a possibly changed formula to deal with mutated viruses. Up to date, more than 500 volunteers have been injected with the vaccine, which confirmed both the safety and effect of the vaccine. The pandemic vaccine will not be made available on the market, but rather be stored for emergency under the guidance of government.